Taimei Technology

Pleasanton, United States Founded: 2013 • Age: 13 yrs Listed
A digital intelligence platform is focused on life sciences activities.

About Taimei Technology

Taimei Technology is a company based in Pleasanton (United States) founded in 2013. Taimei Technology has raised $193.73 million across 4 funding rounds from investors including Tencent, Tiger Global and SBCVC. Taimei Technology operates in a competitive market with competitors including Medidata, Verily, TriNetX, Charles River Laboratories and Signant Health, among others.

  • Headquarter Pleasanton, United States
  • Stage Public
  • Sectors
    Healthcare
  • Website category Computers Electronics and Technology · Search Engines
  • Website taimei.com/en
  • Social LinkedIn
  • Legal Name Zhejiang Taimei Medical Technology Co Ltd Class H
Key Metrics
  • Annual Revenue
    $71.41 M (USD)
    -6.98
    as on Dec 31, 2025
  • Net Profit
    -$5.97 M (USD)
    80.03
    as on Dec 31, 2025
  • EBITDA
    -$7.23 M (USD)
    74.55
    as on Dec 31, 2025
  • Total Equity Funding
    $193.73M (USD)

    in 4 rounds

  • Latest Funding Round
    $131.71M (USD), Series E

    Oct 2019

  • Investors
    Tencent

    & 10 more

Funding Insights of Taimei Technology

Taimei Technology has successfully raised a total of $193.73M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $131.71 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $193.73M
  • Total Rounds 4
  • Last Round Series E β€” $131.71M
  • Investors Count 11

All 4 funding rounds of Taimei Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2019$131.71MSeries E–Tiger Global Management, Tencent
Apr 2018$47.6MSeries D–ZSVC, SBCVC
–
Jan 2017$14.42MSeries C–Matrix Partners China, Northern Light Venture Capital
–
Jun 2016–Series B––
–
Valuation history

11 investors in total: 11 institutional.

Investors in Taimei Technology

Taimei Technology has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Tiger Global and SBCVC.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture and private equity investments are managed with global diversification.
–tigerglobal.comNew York, United States
China-based startups are invested in by SBCVC across diverse sectors.
–sbcvc.comShanghai, China
VC fund investing in startups
–cowinvc.comSuzhou, China
Equity investment management is provided by Zhejiang Venture Capital.
–zsvc.com.cnHangzhou, China
A leading private equity firm supporting high-growth enterprises in Asia.
–saifpartners.com.cnChaoyang, China
Early-stage investments in enterprise services and deep technology are targeted.
–ivycapital.comShanghai, China
-
–cowincapital.com.cn-
A venture capital firm focused on technology and innovation investments.
–5ycap.comShanghai, China
Multiple sectors are invested in by this venture capital firm.
–matrixpartners.com.cnChaoyang, China
Provider of early stage venture capital focused on technology companies
–nlvc.comMenlo Park, United States
Premium access

Investor details for Taimei Technology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Taimei Technology

7 people are tracked at Taimei Technology (5 in leadership, 2 in team).

NameRoleGroup
zhenan yan
CtoLeadership
Wei Fan
Chief Scientist at Taimei, Head of Fleming Research CEO at Taimei USALeadership
Qiao Chao
Head Of SolutionsLeadership
Gary MA
Senior Vice PresidentLeadership
Shou Yuan
Director, Global SolutionsLeadership
Vincent Zhang
Research And Development ManagerTeam
Fifi Zhou
Senior Operations SpecialistTeam
Premium access

Complete people profiles for Taimei Technology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Taimei Technology

Taimei Technology is a publicly listed company on the HKEX with ticker symbol 2576 in Hong Kong, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date08 Oct 2024
  • Listed onHKG: 2576
  • Listed entityZhejiang Taimei Medical Technology Co Ltd Class H
  • Exchange sectorTechnology services
  • ISINCNE100006M66
  • Share price4.50 HKD · 2026-10-12
  • Market capitalisation2,537,005,483.00 HKD
  • EPS (diluted, trailing year)-0.13 HKD
  • Volume (last session)1,352,200

Financials of Taimei Technology

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025555.9M HKD-46.5M HKD-56.3M HKD
2024597.6M HKD-232.7M HKD-221.2M HKD
2023633.3M HKD-383.2M HKD-373.2M HKD
2022638.7M HKD-480.2M HKD-513.2M HKD
2021561.9M HKD-578.0M HKD-528.5M HKD
Premium access

Detailed financial statements for Taimei Technology

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Taimei Technology

4 dated milestones of Taimei Technology across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Taimei Technology is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series E, of $131.7M.
  4. IPO Lists on the stock exchange (IPO).

Competitors of Taimei Technology

Taimei Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Charles River Laboratories and Signant Health, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medidata.com1999New York, United States$41.5M1,677
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
verily.com2015Dallas, United States$2.5B–
AI-based solutions for health management are provided.
trinetx.com2013Cambridge, United States$53M95
Clinical trial management software is provided for researchers and professionals.
criver.com1947Wilmington, United States–21,400
Provider of drug discovery and preclinical development services
signanthealth.com2000Plymouth Meeting, United States$3.4M–
Signant Health is engaged in providing clinical trial technology solutions.
clinicalink.com2006Winston-salem, United States$13.15M283
Paperless eSource and patient engagement solutions for clinical trials
labcorp.com1969Burlington, United States–9,321
Provider of laboratory tests for physicians
cytel.com1987Cambridge, United States$2M509
Data analysis and statistical solutions are provided for life sciences.
precisionmedicinegrp.com2012Bethesda, United States$257.21M2,151
Provider of clinical research, development, and commercialization services for life sciences
Premium access

Detailed competitors of Taimei Technology

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Taimei Technology

The website of Taimei Technology (taimei.com) receives about 14.1K visits a month and ranks #1,303,467 among all websites worldwide, #6,218 in Search Engines.

  • Monthly visits
    14.1K

    ▲ 40% vs previous month

  • Unique visitors
    2.8K

    per month

  • Global rank
    #1,303,467

    among all websites

  • Category rank
    #6,218

    Computers Electronics and Technology · Search Engines

Similar websites

Websites whose visitors overlap most with Taimei Technology. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
baidu.com
100%
1.9B#17View details
google.com
92%
85.8B#1View details
v2ex.com
55%
6.4M#8,092View details
github.com
55%
542.6M#65View details
aliyun.com
aliyun.com
39%
–#1,154–

Latest news on Taimei Technology

Premium access

Complete news archive for Taimei Technology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Taimei Technology

10 companies that operate in the same segment as Taimei Technology (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Taimei Technology

Taimei Technology was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Taimei Technology is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.

Taimei Technology is a funded company, having raised a total of $193.73M across 4 funding rounds to date.

Annual revenue of Taimei Technology is $71.41M as on Dec 31, 2025.

Taimei Technology was founded in 2013 and is based in Pleasanton, United States. Operations center on a digital intelligence platform within the life sciences sector. Services encompass TrialOS, a platform designed for clinical research support, and PharmaOS, a digital tool for collaborative marketing in the life and health industry. These offerings facilitate research and industry collaboration across relevant geographies.

Taimei Technology's top competitors include Medidata, Verily and LabCorp.

Yes, Taimei Technology is publicly traded on HKEX under the ticker symbol 2576.

Taimei Technology has 11 investors. Key investors include Tencent, Tiger Global, SBCVC, Co-win Ventures, and Zhejiang Venture Capital.

Taimei Technology operates through Taimei Technology, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available